Loading organizations...
Loading organizations...
Clinical-stage immunotherapy company developing CAR-T cell therapeutics.
CARsgen Therapeutics has raised $276.0M across 3 funding rounds.
CARsgen Therapeutics has raised $276.0M in total across 3 funding rounds.
CARsgen Therapeutics has raised $276.0M in total across 3 funding rounds.
CARsgen Therapeutics's investors include Loyal Valley Capital, Lilly Asia Ventures, Shiyu Capital, Summer Capital, Photon Fund, Jolly Innovation Ventures, Chi Hoon Hyun, JIC GenesisFountain Healthcare Ventures, Kaitai Capital.
CARsgen Therapeutics has raised $276.0M across 3 funding rounds. Most recently, it raised $186.0M Series C in November 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Nov 3, 2020 | $186.0M Series C | Loyal Valley Capital | Lilly Asia Ventures, Shiyu Capital, Summer Capital |
| Mar 2, 2018 | $60.0M Pre-Series C | Photon Fund | |
| Jan 25, 2016 | $30.0M Series B | Jolly Innovation Ventures, Chi Hoon Hyun | JIC GenesisFountain Healthcare Ventures, Kaitai Capital |